US Patent 8586829 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
Patent 8586829 was granted and assigned to Novozymes A/S on November, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 13 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08586829 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same US Patent 8586829 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
Infobox
Patent Number
0858682900
Patent Number
858682900
Edits on 27 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
085868290
Date of Patent
November 19, 2013
0Patent Application Number
134988410
Date Filed
September 30, 2010
0Official Website
Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
085868290
Date of Patent
November 19, 2013
0Patent Application Number
134988410
Date Filed
September 30, 2010
0Official Website
Patent Primary Examiner
Edits on 19 May, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 21 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08586829 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08586829
Date of patent
November 19, 2013
Patent application number
13498841
Date Filed
September 30, 2010
Patent primary examiner
Find more entities like US Patent 8586829 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
